Cancers colorectaux en 2012: que retenir ?
作者： T. Aparicio , F. Bibeau
DOI: 10.1007/S11725-012-0418-6
关键词: Medicine 、 Gynecology
摘要: Au cours de l’annee 2012 plusieurs avancees pouvant aboutir a une modification des pratiques ont ete presentees. Plusieurs options concernant le depistage du cancer colon sont possibles. La cle la reussite reste taux participation population. Le test fecal semble etre mieux accepte en population europeenne. traitement par antiangiogenique dans les cancers colorectaux metastatique est efficace deuxieme ligne meme apres progression sous premiere comportant un antiangiogenique. anti-EGFR inefficace adjuvant coliques sauf peut-etre pour formes T4N2. Un inhibiteur tyrosine kinase orale fois demontre son efficacite cas colorectal resistant chimiotherapie. chimiotherapie patients âges doit tenir compte parametres geriatriques. determination statut KRAS pourrait facilitee plasmatique, enfin il observe l’apparition clones mutes anti-EGFR.
springer.com
sci-hub.se 参考文章(24)
Ligue contre le cancer Comité de la Corrèze, Institut National du Cancer ,(2012)
T. Aparicio, S. Lavau-Denes, J.M. Phelip, E. Maillard, J.L. Jouve, D. Gargot, M. Gasmi, C. Locher, X. Adhoute, P. Michel, F. Khemissa, T. Lecomte, J. Provençal, G. Breysacher, J.L. Legoux, C. Lepère, J. Charneau, J. Cretin, L. Chone, A. Azzedine, O. Bouché, I. Sobhani, L. Bedenne, E. Mitry, P. Amoyal, D. Auby, J.B. Bachet, M. Baconnier, R. Benoit, O. Berthelet, A. Bidault, C. Bineau, G. Bordes, N. Bouarioua, E. Boucher, O. Boulat, D. Cleau, P. Couzigou, E. Cuillerier, I. Cumin, B. Denis, F. Di Fiore, V. Derias, J. Ezenfis, R. Faroux, A. Gagnaire, G. Gatineau-Sailliant, B. Garcia, D. Genet, A. Gueye, P. Hammel, J.P. Lagasse, B. Landi, C. Lepage, C. Lobry, C. Lombard-Bohas, M. Mabro, R. Mackiewicz, J. Martin, X. Moncoucy, F. Morvan, M. Mozer, M. Pauwels, F. Petit-Laurent, P. Pouderoux, P. Prost, A.M. Queuniet, M. Ramdani, C. Rebischung, P. Rougier, M. Schnee, J.F. Seitz, L. Stefani, J. Taïeb, E. Terrebonne, P. Texereau, J. Thaury, D. Tougeron, A. Weber, F. Ricard, F. Bonnetain, F. Masskouri, C. Choine, F. Guiliani, G. Le Pessec, H. Fattouh, N. Le Provost, C. Girault, M. Schneider, Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02) Annals of Oncology. ,vol. 27, pp. 121- 127 ,(2012) , 10.1093/ANNONC/MDV491
F. Bibeau, H. Frugier, A. Denouel, J.-C. Sabourin, F. Boissiere-Michot, Aspect technique de la détermination du statut KRAS dans le cancer colorectal et mise en place en France. Point de vue de l’anatomopathologiste Bulletin Du Cancer. ,vol. 96, pp. 15- 22 ,(2009) , 10.1684/BDC.2009.0993
Ralf-Dieter Hofheinz, Frederik Wenz, Stefan Post, Axel Matzdorff, Stephan Laechelt, Jörg T Hartmann, Lothar Müller, Hartmut Link, Markus Moehler, Erika Kettner, Elisabeth Fritz, Udo Hieber, Hans Walter Lindemann, Martina Grunewald, Stephan Kremers, Christian Constantin, Matthias Hipp, Gernot Hartung, Deniz Gencer, Peter Kienle, Iris Burkholder, Andreas Hochhaus, Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncology. ,vol. 13, pp. 579- 588 ,(2012) , 10.1016/S1470-2045(12)70116-X
Claus Rödel, Torsten Liersch, Heinz Becker, Rainer Fietkau, Werner Hohenberger, Torsten Hothorn, Ullrich Graeven, Dirk Arnold, Marga Lang-Welzenbach, Hans-Rudolf Raab, Heiko Sülberg, Christian Wittekind, Sergej Potapov, Ludger Staib, Clemens Hess, Karin Weigang-Köhler, Gerhard G Grabenbauer, Hans Hoffmanns, Fritz Lindemann, Anke Schlenska-Lange, Gunnar Folprecht, Rolf Sauer, German Rectal Cancer Study Group, None, Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncology. ,vol. 13, pp. 679- 687 ,(2012) , 10.1016/S1470-2045(12)70187-0
GEORGE J. ROMANES, Physiological Cruelty, or Fact versus Fancy; an Inquiry into the Vivisection Question Nature. ,vol. 28, pp. 537- 538 ,(1883) , 10.1038/028537A0
Florence Boissière-Michot, Evelyne Lopez-Crapez, Hélène Frugier, Marie-Laurence Berthe, Alexandre Ho-Pun-Cheung, Eric Assenat, Thierry Maudelonde, Pierre-Jean Lamy, Frédéric Bibeau, KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment Modern Pathology. ,vol. 25, pp. 731- 739 ,(2012) , 10.1038/MODPATHOL.2011.210
Sandra Misale, Rona Yaeger, Sebastijan Hobor, Elisa Scala, Manickam Janakiraman, David Liska, Emanuele Valtorta, Roberta Schiavo, Michela Buscarino, Giulia Siravegna, Katia Bencardino, Andrea Cercek, Chin-Tung Chen, Silvio Veronese, Carlo Zanon, Andrea Sartore-Bianchi, Marcello Gambacorta, Margherita Gallicchio, Efsevia Vakiani, Valentina Boscaro, Enzo Medico, Martin Weiser, Salvatore Siena, Federica Di Nicolantonio, David Solit, Alberto Bardelli, Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer Nature. ,vol. 486, pp. 532- 536 ,(2012) , 10.1038/NATURE11156
F Di Fiore, R Sesboüé, P Michel, J C Sabourin, T Frebourg, Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer British Journal of Cancer. ,vol. 103, pp. 1765- 1772 ,(2010) , 10.1038/SJ.BJC.6606008
Mark J. Alberts, Cerebral Hemorrhage, Warfarin, and Intravenous tPA JAMA. ,vol. 307, pp. 2637- 2639 ,(2012) , 10.1001/JAMA.2012.7265